Machine Learning in Drug Metabolism Study

被引:3
|
作者
Sinha, Krishnendu [1 ]
Ghosh, Jyotirmoy [2 ]
Sil, Parames Chandra [3 ,4 ]
机构
[1] Jhargram Raj Coll, Dept Zool, Jhargram 721507, India
[2] Banwarilal Bhalotia Coll, Dept Chem, Asansol 713303, India
[3] Bose Inst, Dept Div Mol Med, Kolkata 700054, India
[4] Bose Inst, Div Mol Med, Kolkata 700054, India
关键词
Machine learning; algorithms; deep learning; drug metabolism; metabolites; molecular docking; PHASE-I; PREDICTION; FUTURE; MECHANISMS; DISCOVERY; TOXICITY; NETWORK; MODELS; WEB;
D O I
10.2174/1389200224666221227094144
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolic reactions in the body transform the administered drug into metabolites. These metabolites exhibit diverse biological activities. Drug metabolism is the major underlying cause of drug overdose-related toxicity, adversative drug effects and the drug's reduced efficacy. Though metabolic reactions deactivate a drug, drug metabolites are often considered pivotal agents for off-target effects or toxicity. On the other side, in combination drug therapy, one drug may influence another drug's metabolism and clearance and is thus considered one of the primary causes of drug-drug interactions. Today with the advancement of machine learning, the metabolic fate of a drug candidate can be comprehensively studied throughout the drug development procedure. Naive Bayes, Logistic Regression, k-Nearest Neighbours, Decision Trees, different Boosting and Ensemble methods, Support Vector Machines and Artificial Neural Network boosted Deep Learning are some machine learning algorithms which are being extensively used in such studies. Such tools are covering several attributes of drug metabolism, with an emphasis on the prediction of drug-drug interactions, drug-target-interactions, clinical drug responses, metabolite predictions, sites of metabolism, etc. These reports are crucial for evaluating metabolic stability and predicting prospective drug-drug interactions, and can help pharmaceutical companies accelerate the drug development process in a less resource-demanding manner than what in vitro studies offer. It could also help medical practitioners to use combinatorial drug therapy in a more resourceful manner. Also, with the help of the enormous growth of deep learning, traditional fields of computational drug development like molecular interaction fields, molecular docking, quantitative structure-to-activity relationship (QSAR) studies and quantum mechanical simulations are producing results which were unimaginable couple of years back. This review provides a glimpse of a few contextually relevant machine learning algorithms and then focuses on their outcomes in different studies.
引用
收藏
页码:1012 / 1026
页数:15
相关论文
共 50 条
  • [41] A Comprehensive Study on Nanoparticle Drug Delivery to the Brain: Application of Machine Learning Techniques
    Yousfan, Amal
    Al Rahwanji, Mhd Jawad
    Hanano, Abdulsamie
    Al-Obaidi, Hisham
    MOLECULAR PHARMACEUTICS, 2023, 21 (01) : 333 - 345
  • [42] Machine Learning in High-Alert Medication Treatment: A Study on the Cardiovascular Drug
    Tai, Chun-Tien
    Sue, Kuen-Liang
    Hu, Ya-Han
    APPLIED SCIENCES-BASEL, 2020, 10 (17):
  • [43] Applied Machine Learning Toward Drug Discovery Enhancement: Leishmaniases as a Case Study
    Harigua-Souiai, Emna
    Oualha, Rafeh
    Souiai, Oussama
    Abdeljaoued-Tej, Ines
    Guizani, Ikram
    BIOINFORMATICS AND BIOLOGY INSIGHTS, 2022, 16
  • [44] A machine learning framework for predicting drug-drug interactions
    Mei, Suyu
    Zhang, Kun
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [45] Synergistic drug combinations and machine learning for drug repurposing in chordoma
    Edward Anderson
    Tammy M. Havener
    Kimberley M. Zorn
    Daniel H. Foil
    Thomas R. Lane
    Stephen J. Capuzzi
    Dave Morris
    Anthony J. Hickey
    David H. Drewry
    Sean Ekins
    Scientific Reports, 10
  • [46] Synergistic drug combinations and machine learning for drug repurposing in chordoma
    Anderson, Edward
    Havener, Tammy M.
    Zorn, Kimberley M.
    Foil, Daniel H.
    Lane, Thomas R.
    Capuzzi, Stephen J.
    Morris, Dave
    Hickey, Anthony J.
    Drewry, David H.
    Ekins, Sean
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [47] From machine learning to deep learning: progress in machine intelligence for rational drug discovery
    Zhang, Lu
    Tan, Jianjun
    Han, Dan
    Zhu, Hao
    DRUG DISCOVERY TODAY, 2017, 22 (11) : 1680 - 1685
  • [48] Electrochemical study of drug metabolism
    Nikzad, Nastaran
    Rafiee, Mohammad
    CURRENT OPINION IN ELECTROCHEMISTRY, 2024, 44
  • [49] GENETIC STUDY OF DRUG METABOLISM
    PRICEEVA.DA
    CHEMICO-BIOLOGICAL INTERACTIONS, 1971, 3 (04) : 262 - +
  • [50] Drug design by machine learning: Ensemble learning for QSAR modeling
    Liu, Y
    ICMLA 2005: FOURTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, 2005, : 187 - 193